C. Wack

Phase I study of cabazitaxel plus cisplatin in patients with advanced solid tumors: study to evaluate the impact of cytochrome P450 3A inhibitors (aprepitant, ketoconazole) or inducers (rifampin) on the pharmacokinetics of cabazitaxel

A. Craig Lockhart, John C. Morris, A. Lockhart, 2014, Cancer Chemotherapy and Pharmacology.

A phase I pharmacokinetic and safety study of cabazitaxel in adult cancer patients with normal and impaired renal function

J. Machiels, R. Mathijssen, M. D. de Jonge, 2016, Cancer Chemotherapy and Pharmacology.

A phase 1b study of isatuximab plus lenalidomide and dexamethasone for relapsed/refractory multiple myeloma.

R. Vij, A. Lesokhin, P. Munster, 2017, Blood.

Plateable cryopreserved human hepatocytes for the assessment of cytochrome P450 inducibility: experimental condition-related variables affecting their response to inducers

P. Bachellier, L. Richert, C. Parmentier, 2012, Xenobiotica; the fate of foreign compounds in biological systems.

Phase I dose-escalation study of cabazitaxel administered in combination with cisplatin in patients with advanced solid tumors

Jennifer L Moseley, A. Lockhart, M. Mita, 2014, Investigational New Drugs.

Preliminary Results from a Phase Ib Study of Isatuximab in Combination with Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

P. Richardson, N. Raje, S. Usmani, 2016 .

Safety and pharmacokinetics of cabazitaxel in patients with hepatic impairment: a phase I dose-escalation study

A. Lockhart, J. Mier, C. Hsueh, 2017, Cancer Chemotherapy and Pharmacology.

Preliminary Results From a Phase Ib Study of Isatuximab in Combination with Pomalidomide (Pom) and Dexamethasone (Dex) in Relapsed and Refractory Multiple Myeloma (RRMM)

P. Richardson, S. Usmani, W. Bensinger, 2017 .

Absence of interaction of cabazitaxel on the pharmacokinetics of midazolam: Results of a drug-drug interaction study in patients with advanced solid tumors.

S. Ross, A. Lockhart, C. Hsueh, 2013, Journal of Clinical Oncology.

Interaction of quinolones with the theophylline metabolism in man: investigations with lomefloxacin and pipemidic acid.

U. Fuhr, A. Staib, S. Harder, 1989, International journal of clinical pharmacology, therapy, and toxicology.